Seizure activity results in calcium- and mitochondriaindependent ros production via nadph and xanthine oxidase activation

Cell Death and Disease

Volumn 5, Issue 10, 2014, Pages

  Kovac, S ^a,b   Domijan, A M ^c   Walker, M C ^a   Abramov, A Y ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; XANTHINE OXIDASE; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; SODIUM;

APOPTOSIS; ARTICLE; CALCIUM CELL LEVEL; CELL CULTURE; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME ACTIVATION; ENZYME ACTIVITY; IN VITRO STUDY; MITOCHONDRION; NERVE CELL NECROSIS; PRIORITY JOURNAL; SEIZURE; ANIMAL; CYTOLOGY; ENZYMOLOGY; GENETICS; HUMAN; METABOLISM; NERVE CELL; OXIDATIVE STRESS; PATHOPHYSIOLOGY; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; CALCIUM; HUMANS; MITOCHONDRIA; NADP; NADPH OXIDASE; NEURONS; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; RECEPTORS, N-METHYL-D-ASPARTATE; SEIZURES; SODIUM; XANTHINE OXIDASE;

EID: 84921875050     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.390     Document Type: Article

References (55)

1. Abramov AY, Canevari L, Duchen MR. Beta-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase. J Neurosci 2004; 24: 565-575.
2. Chinta SJ, Andersen JK. Redox imbalance in Parkinson's disease. Biochim Biophys Acta 2008; 1780: 1362-1367.
3. Gandhi S, Wood-Kaczmar A, Yao Z, Plun-Favreau H, Deas E, Klupsch K et al. PINK1-associated Parkinson's disease is caused by neuronal vulnerability to calciuminduced cell death. Mol Cell 2009; 33: 627-638.
4. Halliwell B. Oxidative stress and neurodegeneration: where are we now? J Neurochem 2006; 97: 1634-1658.
5. Abramov AY, Scorziello A, Duchen MR. Three distinct mechanisms generate oxygen free radicals in neurons and contribute to cell death during anoxia and reoxygenation. J Neurosci 2007; 27: 1129-1138.
6. Slemmer JE, Shacka JJ, Sweeney MI, Weber JT. Antioxidants and free radical scavengers for the treatment of stroke, traumatic brain injury and aging. Curr Med Chem 2008; 15:404-414.
7. Frantseva MV, Velazquez JL, Hwang PA, Carlen PL. Free radical production correlates with cell death in an in vitro model of epilepsy. Eur J Neurosci 2000; 12: 1431-1439.
8. Malinska D, Kulawiak B, Kudin AP, Kovacs R, Huchzermeyer C, Kann O et al. Complex IIIdependent superoxide production of brain mitochondria contributes to seizure-related ROS formation. Biochim Biophys Acta 2010; 1797: 1163-1170.
9. Pestana RRF, Kinjo ER, Hernandes MS, Britto LRG. Reactive oxygen species generated by NADPH oxidase are involved in neurodegeneration in the pilocarpine model of temporal lobe epilepsy. Neurosci Lett 2010; 484: 187-191.
10. Waldbaum S, Patel M. Mitochondrial dysfunction and oxidative stress: a contributing link to acquired epilepsy?. J Bioenerg Biomembr 2010; 42: 449-455.
11. Tsai H-L, Chang C-N, Chang S-J. The effects of pilocarpine-induced status epilepticus on oxidative stress/damage in developing animals. Brain Dev 2010; 32: 25-31.
12. Layton ME, Pazdernik TL. Reactive oxidant species in piriform cortex extracellular fluid during seizures induced by systemic kainic acid in rats. J Mol Neurosci 1999; 13: 63-68.
13. Wang X, Fang H, Huang Z, Shang W, Hou T, Cheng A et al. Imaging ROS signaling in cells and animals. J Mol Med (Berl) 2013; 91: 917-927.
14. Kovács R, Kardos J, Heinemann U, Kann O. Mitochondrial calcium ion and membrane potential transients follow the pattern of epileptiform discharges in hippocampal slice cultures. J Neurosci 2005; 25: 4260-4269.
15. Schauwecker PE. Neuroprotection by glutamate receptor antagonists against seizureinduced excitotoxic cell death in the aging brain. Exp Neurol 2010; 224: 207-218.
16. Girouard H, Wang G, Gallo EF, Anrather J, Zhou P, Pickel VM et al. NMDA receptor activation increases free radical production through nitric oxide and NOX2. J Neurosci 2009;29: 2545-2552.
17. Brennan AM, Suh SW, Won SJ, Narasimhan P, Kauppinen TM, Lee H et al. NADPH oxidase is the primary source of superoxide induced by NMDA receptor activation. Nat Neurosci 2009; 12: 857-863
18. Schiavone S, Jaquet V, Sorce S, Dubois-Dauphin M, Hultqvist M, Bäckdahl L et al. NADPH oxidase elevations in pyramidal neurons drive psychosocial stress-induced neuropathology. Transl Psychiatry 2012; 2: e111.
19. Cristóvão AC, Guhathakurta S, Bok E, Je G, Yoo SD, Choi D-H et al. NADPH oxidase 1 mediates a-synucleinopathy in Parkinson's disease. J Neurosci 2012; 32:14465-14477.
20. Di Maio R, Mastroberardino PG, Hu X, Montero L, Greenamyre JT. Pilocapine alters NMDA receptor expression and function in hippocampal neurons: NADPH oxidase and ERK1/2 mechanisms. Neurobiol Dis 2011; 42: 482-495.
21. DeLorenzo RJ, Pal S, Sombati S. Prolonged activation of the N-methyl-D-aspartate receptor-Ca2+ transduction pathway causes spontaneous recurrent epileptiform discharges in hippocampal neurons in culture. Proc Natl Acad Sci USA 1998; 95: 14482-14487.
22. Blair RE, Deshpande LS, Sombati S, Elphick MR, Martin BR, DeLorenzo RJ. Prolonged exposure to WIN55,212-2 causes downregulation of the CB1 receptor and the development of tolerance to its anticonvulsant effects in the hippocampal neuronal culture model of acquired epilepsy. Neuropharmacology 2009; 57: 208-218.
23. Kovac S, Domijan A-M, Walker MC, Abramov AY. Prolonged seizure activity impairs mitochondrial bioenergetics and induces cell death. J Cell Sci. 2012; 125(Part 7):1796-1806.
24. Kovacs R, Kardos J, Heinemann U, Kann O. Mitochondrial calcium ion and membrane potential transients follow the pattern of epileptiform discharges in hippocampal slice cultures. J Neurosci 2005; 25: 4260-4269.
25. Kovacs R, Schuchmann S, Gabriel S, Kardos J, Heinemann U. Ca2+ signalling and changes of mitochondrial function during low-Mg2+-induced epileptiform activity in organotypic hippocampal slice cultures. Eur J Neurosci 2001; 13: 1311-1319.
26. Barbarosie M, Avoli M. CA3-driven hippocampal-entorhinal loop controls rather than sustains in vitro limbic seizures. J Neurosci 1997; 17: 9308-9314.
27. Barkai E, Friedman A, Grossman Y, Gutnick MJ. Laminar pattern of synaptic inhibition during convulsive activity induced by 4-aminopyridine in neocortical slices. J Neurophysiol 1995; 73: 1462-1467.
28. Sun DA, Sombati S, DeLorenzo RJ. Glutamate injury-induced epileptogenesis in hippocampal neurons: an in vitro model of stroke-induced 'epilepsy'. Stroke 2001; 32: 2344-2350.
29. DeLorenzo RJ, Sun DA, Deshpande LS. Cellular mechanisms underlying acquired epilepsy: the calcium hypothesis of the induction and maintainance of epilepsy. Pharmacol Ther 2005; 105: 229.
30. Diatchuk V, Lotan O, Koshkin V, Wikstroem P, Pick E. Inhibition of NADPH oxidase activation by 4-(2-aminoethyl)-benzenesulfonyl fluoride and related compounds. J Biol Chem 1997; 272: 13292-13301.
31. Kinugasa Y, Ogino K, Furuse Y, Shiomi T, Tsutsui H, Yamamoto T et al. Allopurinol improves cardiac dysfunction after ischemia-reperfusion via reduction of oxidative stress in isolated perfused rat hearts. Circ J 2003; 67: 781-787.
32. Xia Y, Zweier JL. Substrate control of free radical generation from xanthine oxidase in the postischemic heart. J Biol Chem 1995; 270: 18797-18803.
33. Rey FE, Cifuentes ME, Kiarash A, Quinn MT, Pagano PJ. Novel competitive inhibitor of NAD (P)H oxidase assembly attenuates vascular O(2)(-) and systolic blood pressure in mice. Circ Res 2001; 89: 408-414.
34. Elnakish MT, Hassanain HH, Janssen PM, Angelos MG, Khan M. Emerging role of oxidative stress in metabolic syndrome and cardiovascular diseases: important role of Rac/NADPH oxidase. J Pathol 2013; 231: 290-300.
35. Kovács R, Schuchmann S, Gabriel S, Kann O, Kardos J, Heinemann U. Free radicalmediated cell damage after experimental status epilepticus in hippocampal slice cultures. J Neurophysiol 2002; 88: 2909-2918.
36. Mangan PS, Kapur J. Factors underlying bursting behavior in a network of cultured hippocampal neurons exposed to zero magnesium. J Neurophysiol 2004; 91: 946-957.
37. Hardingham GE, Fukunaga Y, Bading H. Extrasynaptic NMDARs oppose synaptic NMDARs by triggering CREB shut-off and cell death pathways. Nat Neurosci 2002; 5: 405-414.
38. Liu F-Y, Wang X-F, Li M-W, Li J-M, Xi Z-Q, Luan G-M et al. Upregulated expression of postsynaptic density-93 and N-methyl-D-aspartate receptors subunits 2B mRNA in temporal lobe tissue of epilepsy. Biochem Biophys Res Commun 2007; 358: 825-830.
39. Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 1994;12: 529-540.
40. Tovar KR, Westbrook GL. The incorporation of NMDA receptors with a distinct subunit composition at nascent hippocampal synapses in vitro. J Neurosci 1999; 19: 4180-4188.
41. Bedard K, Krause K-H. The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007; 87: 245-313.
42. Balteau M, Tajeddine N, de Meester C, Ginion A, Des Rosiers C, Brady NR et al. NADPH oxidase activation by hyperglycaemia in cardiomyocytes is independent of glucose metabolism but requires SGLT1. Cardiovasc Res 2011; 92: 237-246.
43. Rathje M, Fang H, Bachman JL, Anggono V, Gether U, Huganir RL et al. AMPA receptor pHluorin-GluA2 reports NMDA receptor-induced intracellular acidification in hippocampal neurons. Proc Natl Acad Sci USA 2013; 110: 14426-14431.
44. Patel M, Li Q-Y, Chang L-Y, Crapo J, Liang L-P. Activation of NADPH oxidase and extracellular superoxide production in seizure-induced hippocampal damage. J Neurochem 2005; 92: 123-131.
45. Kim JH, Jang BG, Choi BY, Kim HS, Sohn M, Chung TN et al. Post-treatment of an NADPH oxidase inhibitor prevents seizure-induced neuronal death. Brain Res 2013; 1499: 163-172.
46. Kramer LD, Locke GE, Nelson LG, Ogunyemi AO. Status epilepticus following withdrawal of allopurinol. Ann Neurol 1990; 27: 691.
47. Tada H, Morooka K, Arimoto K, Matsuo T. Clinical effects of allopurinol on intractable epilepsy. Epilepsia 1991; 32: 279-283.
48. Zagnoni PG, Bianchi A, Zolo P, Canger R, Cornaggia C, D'Alessandro P et al. Allopurinol as add-on therapy in refractory epilepsy: a double-blind placebo-controlled randomized study. Epilepsia 1994; 35: 107-112.
49. Cock H. The role of mitochondria in status epilepticus. Epilepsia 2007; 48: 24-27.
50. Liang L-P, Patel M. Mitochondrial oxidative stress and increased seizure susceptibility in Sod2( -/+) mice. Free Radic Biol Med 2004; 36(Suppl 8): 542-554.
51. Liang L-P, Patel M. Seizure-induced changes in mitochondrial redox status. Free Radic Biol Med 2006; 40: 316-322.
52. Cock HR, Tong X, Hargreaves IP, Heales SJR, Clark JB, Patsalos PN et al. Mitochondrial dysfunction associated with neuronal death following status epilepticus in rat. Epilepsy Res 2002; 48: 157-168.
53. Budd SL, Castilho RF, Nicholls DG. Mitochondrial membrane potential and hydroethidinemonitored superoxide generation in cultured cerebellar granule cells. FEBS Lett 1997; 415:21-24.
54. Nicholls DG. Mitochondria and calcium signaling. Cell Calcium 2005; 38: 311-317.
55. Haynes LW. The Neuron in Tissue Culture. New Yok, NY, USA: Wiley, 1999.